Alector Inc.

24.04-0.0300-0.12%Vol 1.31M1Y Perf 44.64%
Jul 30th, 2021 16:00 DELAYED
BID24.20 ASK24.33
Open24.01 Previous Close24.07
Pre-Market- After-Market-
 - -  - -%
Target Price
38.80 
Analyst Rating
Strong Buy 1.07
Potential %
61.40 
Finscreener Ranking
★★★+     52.46
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★+     49.31
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★+     55.09
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap1.92B 
Earnings Rating
Buy
Price Range Ratio 52W %
43.63 
Earnings Date
10th Aug 2021

Today's Price Range

23.3224.81

52W Range

9.1243.32

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Week
-26.64%
1 Month
15.41%
3 Months
23.28%
6 Months
42.76%
1 Year
44.64%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ALEC24.04-0.0300-0.12
AAPL145.860.22000.15
GOOG2 704.42-26.3900-0.97
MSFT284.91-1.5900-0.55
XOM57.57-1.3600-2.31
WFC45.94-0.5600-1.20
JNJ172.200.02000.01
FB356.30-2.0200-0.56
GE12.95-0.3400-2.56
JPM151.78-1.2200-0.80
ValuationValueIndustryS&P 500US Markets
-12.70
11.47
163.27
10.70
-18.20
-2.37
11.47
2.86
2.30B
Forward PE-23.07
PEG-0.38
Financial StrengthValueIndustryS&P 500US Markets
5.70
5.80
0.16
0.22
-
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
-
-1 140.60
-1 098.90
-1 217.80
-
RevenueValueIndustryS&P 500US Markets
14.87M
0.19
-0.29
-
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.68-0.662.94
Q04 2020-0.61-0.66-8.20
Q03 2020-0.54-0.67-24.07
Q02 2020-0.52-0.58-11.54
Q01 2020-0.48-0.53-10.42
Q04 2019-0.44-0.45-2.27
Q03 2019-0.42-0.47-11.90
Q02 2019-0.33-0.36-9.09
Earnings Per EndEstimateRevision %Trend
6/2021 QR-0.692.82Positive
9/2021 QR-0.5716.18Positive
12/2021 FY-2.1224.82Positive
12/2022 FY-1.4249.29Positive
Next Report Date10th Aug 2021
Estimated EPS Next Report-0.69
Estimates Count5
EPS Growth Next 5 Years %33.00
Volume Overview
Volume1.31M
Shares Outstanding79.77M
Trades Count15.82K
Dollar Volume11.30M
Avg. Volume1.00M
Avg. Weekly Volume1.40M
Avg. Monthly Volume3.46M
Avg. Quarterly Volume1.51M

Alector Inc. (NASDAQ: ALEC) stock closed at 24.04 per share at the end of the most recent trading day (a -0.12% change compared to the prior day closing price) with a volume of 1.32M shares and market capitalization of 1.92B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 171 people. Alector Inc. CEO is Arnon Rosenthal.

The one-year performance of Alector Inc. stock is 44.64%, while year-to-date (YTD) performance is 58.89%. ALEC stock has a five-year performance of %. Its 52-week range is between 9.12 and 43.32, which gives ALEC stock a 52-week price range ratio of 43.63%

Alector Inc. currently has a PE ratio of -12.70, a price-to-book (PB) ratio of 11.47, a price-to-sale (PS) ratio of 163.27, a price to cashflow ratio of 10.70, a PEG ratio of 2.32, a ROA of -36.84%, a ROC of -56.41% and a ROE of -62.80%. The company’s profit margin is -%, its EBITDA margin is -1 098.90%, and its revenue ttm is $14.87 Million , which makes it $0.19 revenue per share.

Of the last four earnings reports from Alector Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.69 for the next earnings report. Alector Inc.’s next earnings report date is 10th Aug 2021.

The consensus rating of Wall Street analysts for Alector Inc. is Strong Buy (1.07), with a target price of $38.8, which is +61.40% compared to the current price. The earnings rating for Alector Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Alector Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Alector Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.58, ATR14 : 2.92, CCI20 : -190.39, Chaikin Money Flow : -0.15, MACD : 0.32, Money Flow Index : 35.10, ROC : -33.72, RSI : 38.12, STOCH (14,3) : 4.53, STOCH RSI : 0.00, UO : 31.33, Williams %R : -95.47), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Alector Inc. in the last 12-months were: Calvin Yu (Option Excercise at a value of $842 377), Calvin Yu (Sold 116 018 shares of value $3 777 368 ), Robert King (Option Excercise at a value of $304 200), Robert King (Sold 60 000 shares of value $1 868 400 ), Robert Paul (Option Excercise at a value of $3 526 302), Robert Paul (Sold 389 750 shares of value $9 177 858 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (85.71 %)
6 (85.71 %)
6 (85.71 %)
Moderate Buy
1 (14.29 %)
1 (14.29 %)
1 (14.29 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.07
Strong Buy
1.07
Strong Buy
1.07

Alector Inc.

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain.

CEO: Arnon Rosenthal

Telephone: +1 415 231-5660

Address: 131 Oyster Point Boulevard, South San Francisco 94080, CA, US

Number of employees: 171

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

54%46%

Bearish Bullish

50%50%

News

Stocktwits